Merck stock trades steadily as Keytruda and vaccine revenue underpin earnings

Merck stock trades steadily as Keytruda and vaccine revenue underpin earnings  Ad-hoc-news.de

Summary aggregated from Ad-hoc-news.de's public RSS feed. The full reporting belongs to Ad-hoc-news.de — please read it on their site.